myTomorrows is a global health tech company that facilitates access to treatment options for patients. The company connects patients, healthcare professionals, trial sites, patient advocacy groups, and biopharmaceutical companies, effectively bridging the gap in the drug development ecosystem. Their AI-powered technology platform streamlines the process of accessing drugs in development, with services that include clinical trial patient recruitment, Expanded Access Program management, and real-world data collection. Operating across 125 countries, myTomorrows has supported over 15,000 patients and 2,400 physicians, building trust with more than 50 biopharma companies. The mission is to shape the future of treatment access, ensuring that promising therapies are available to those who need them today.